{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:56:25Z","timestamp":1773676585016,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Swedish Foundation for Strategic Research, \u201cTOTAL-AMI\u201d, Swedish Academy of Pharmaceutical Sciences, Swedish Research Council, Vinnova, Ingabritt & Arne Lundbergs forskningsstiftelse"},{"DOI":"10.13039\/501100003173","name":"Crafoord Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jprot.2013.05.016","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T08:23:42Z","timestamp":1369297422000},"page":"16-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction"],"prefix":"10.1016","volume":"87","author":[{"given":"Melinda","family":"Rezeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1kos","family":"V\u00e9gv\u00e1ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Donnarumma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Gidl\u00f6f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Gustav","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Erlinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Marko-Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2013.05.016_bb0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/2047487312450228","article-title":"European guidelines on cardiovascular disease prevention in clinical practice (version 2012)","volume":"19","author":"Perk","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jprot.2013.05.016_bb0010","doi-asserted-by":"crossref","first-page":"635-U119","DOI":"10.1038\/nbt.1899","article-title":"A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease","volume":"29","author":"Addona","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jprot.2013.05.016_bb0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCRESAHA.110.225003","article-title":"Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics","volume":"109","author":"Gerszten","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jprot.2013.05.016_bb0020","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cbpa.2009.09.014","article-title":"Perspectives of targeted mass spectrometry for protein biomarker verification","volume":"13","author":"Huttenhain","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jprot.2013.05.016_bb0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/prca.201000057","article-title":"Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective","volume":"4","author":"Rodriguez","year":"2010","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2013.05.016_bb0030","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1373\/clinchem.2010.150383","article-title":"The increasing role of mass spectrometry in quantitative clinical proteomics","volume":"56","author":"Whiteaker","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jprot.2013.05.016_bb0035","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1074\/mcp.M800446-MCP200","article-title":"SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device","volume":"8","author":"Anderson","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2013.05.016_bb0040","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1373\/clinchem.2009.123935","article-title":"Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry","volume":"55","author":"Kuhn","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jprot.2013.05.016_bb0045","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1021\/pr300652v","article-title":"High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography\u2013free mass spectrometry","volume":"11","author":"Razavi","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2013.05.016_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1373\/clinchem.2009.137323","article-title":"Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants","volume":"56","author":"Lopez","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jprot.2013.05.016_bb0055","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1021\/ac3018873","article-title":"N-15-labeled full-length apolipoprotein E4 as an internal standard for mass spectrometry quantification of apolipoprotein E isoforms","volume":"84","author":"Wang","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.jprot.2013.05.016_bb0060","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/rcm.3130","article-title":"The application of ultra-performance liquid chromatography\/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum","volume":"21","author":"Kay","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.jprot.2013.05.016_bb0065","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/pmic.201100568","article-title":"MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma","volume":"12","author":"Domanski","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.05.016_bb0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1373\/clinchem.2009.127878","article-title":"Integration of proteomic-based tools for improved biomarkers of myocardial injury","volume":"56","author":"Gerszten","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jprot.2013.05.016_bb0075","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1373\/clinchem.2010.152264","article-title":"Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography\u2013multiple-reaction-monitoring mass spectrometry","volume":"56","author":"Agger","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jprot.2013.05.016_bb0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(08)61076-4","article-title":"Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case\u2013control study","volume":"372","author":"McQueen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jprot.2013.05.016_bb0085","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/eurjhf\/hfp129","article-title":"Lipoprotein components and risk of congestive heart failure in 84740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)","volume":"11","author":"Holme","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jprot.2013.05.016_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1373\/clinchem.2009.126706","article-title":"The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum","volume":"56","author":"Anderson","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jprot.2013.05.016_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jprot.2011.05.042","article-title":"MRM assay for quantitation of complement components in human blood plasma \u2014 a feasibility study on multiple sclerosis","volume":"75","author":"Rezeli","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/j.jprot.2013.05.016_bb0100","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1021\/ac102179j","article-title":"Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry","volume":"82","author":"MacLean","year":"2010","journal-title":"Anal Chem"},{"key":"10.1016\/j.jprot.2013.05.016_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2008.61","article-title":"Selected reaction monitoring for quantitative proteomics: a tutorial","volume":"4","author":"Lange","year":"2008","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jprot.2013.05.016_bb0110","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1074\/mcp.M800540-MCP200","article-title":"Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma","volume":"8","author":"Kuzyk","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2013.05.016_bb0115","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jprot.2013.05.016_bb0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2119\/molmed.2010-00044","article-title":"APOE\/C1\/C4\/C2 gene cluster genotypes, haplotypes and lipid levels in prospective coronary heart disease risk among UK healthy men","volume":"16","author":"Ken-Dror","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.jprot.2013.05.016_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/pr1008515","article-title":"On the development of plasma protein biomarkers","volume":"10","author":"Surinova","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2013.05.016_bb0130","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/prca.200780174","article-title":"The interface between biomarker discovery and clinical validation: the tar pit of the protein biomarker pipeline","volume":"2","author":"Paulovich","year":"2008","journal-title":"Proteomics Clin Appl"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391913002571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391913002571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T20:59:26Z","timestamp":1539637166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391913002571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":26,"alternative-id":["S1874391913002571"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2013.05.016","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2013.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}